Sumitomo Mitsui Trust Holdings, Inc. Fate Therapeutics Inc Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

$142 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	SELL	$9.86 - $23.83 $3.76 Million - $9.08 Million	-380,928 Reduced 29.56%	907,930 $9.16 Million
Q3 2022 Oct 21, 2022	BUY	$21.04 - $36.06 $384,884 - $659,645	18,293 Added 1.44%	1,288,858 $28.9 Million
Q2 2022 Jul 26, 2022	BUY	$17.78 - $42.39 $136,888 - $326,360	7,699 Added 0.61%	1,270,565 $31.5 Million
Q1 2022 Apr 27, 2022	BUY	$29.67 - $60.28 $594,082 - $1.21 Million	20,023 Added 1.61%	1,262,866 $49 Million
Q4 2021 Feb 02, 2022	SELL	$47.84 - $64.34 $178,299 - $239,795	-3,727 Reduced 0.3%	1,242,843 $72.7 Million
Q3 2021 Oct 25, 2021	BUY	$59.27 - $95.73 $12.7 Million - $20.5 Million	214,490 Added 20.78%	1,246,570 $73.9 Million
Q2 2021 Aug 02, 2021	BUY	$67.25 - $92.52 $31.6 Million - $43.5 Million	470,485 Added 83.78%	1,032,080 $89.6 Million
Q1 2021 Apr 30, 2021	BUY	$72.16 - $117.4 $1.73 Million - $2.81 Million	23,931 Added 4.45%	561,595 $46.3 Million
Q4 2020 Feb 05, 2021	BUY	$38.09 - $100.95 $2.1 Million - $5.58 Million	55,238 Added 11.45%	537,664 $48.9 Million
Q3 2020 Oct 30, 2020	SELL	$30.41 - $40.5 $1.51 Million - $2.02 Million	-49,778 Reduced 9.35%	482,426 $19.3 Million
Q2 2020 Jul 27, 2020	SELL	$20.21 - $35.23 $7.96 Million - $13.9 Million	-393,805 Reduced 42.53%	532,204 $18.3 Million
Q1 2020 Apr 27, 2020	BUY	$17.28 - $31.88 $1.84 Million - $3.39 Million	106,199 Added 12.95%	926,009 $20.6 Million
Q4 2019 Jan 31, 2020	SELL	$13.39 - $20.73 $276,101 - $427,452	-20,620 Reduced 2.45%	819,810 $16 Million
Q3 2019 Oct 31, 2019	BUY	$15.47 - $22.5 $5.13 Million - $7.46 Million	331,589 Added 65.17%	840,430 $13.1 Million
Q2 2019 Jul 29, 2019	BUY	$15.61 - $20.44 $7.94 Million - $10.4 Million	508,841 New	508,841 $10.3 Million

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $222M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Account